Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass graft (CABG): a randomized controlled trial

ISRCTN ISRCTN95608630
DOI https://doi.org/10.1186/ISRCTN95608630
Secondary identifying numbers CH0401
Submission date
24/08/2005
Registration date
26/08/2005
Last edited
29/11/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Cornelia Hoedemaekers
Scientific

Geert Grooteplein 10
Nijmegen
6500 HB
Netherlands

Email C.Hoedemaekers@ic.umcn.nl

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific title
Study acronymCH0401
Study objectivesStrict glucose control in critically ill patients alters the cytokine balance towards a more pro-inflammatory state.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedCoronary artery bypass graft
InterventionStrict glucose control (blood glucose between 80-110 mg/dl) versus placebo (blood glucose >200 mg/dl).
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Insulin
Primary outcome measureCytokine levels
Secondary outcome measuresComplement concentration
Overall study start date01/09/2003
Completion date01/11/2004

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants20
Key inclusion criteria1. Adults, after uncomplicated CABG
2. Non-diabetics
Key exclusion criteria1. Diabetes
2. Renal failure
3. Use of anti-inflammatory drugs
4. Recent myocardial ischemia
Date of first enrolment01/09/2003
Date of final enrolment01/11/2004

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Geert Grooteplein 10
Nijmegen
6500 HB
Netherlands

Sponsor information

Radboud University Nijmegen Medical Centre (The Netherlands)
Hospital/treatment centre

Geert Groteplein 10
Nijmegen
6500 HB
Netherlands

Phone +31 (0)24 3617273
Email H.vanderHoeven@ic.umcn.nl
ROR logo "ROR" https://ror.org/05wg1m734

Funders

Funder type

Hospital/treatment centre

The Department of Intensive Care, Radboud University Nijmegen Medical Centre

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 01/09/2005 Yes No